If this feature is combined with a manual prandial bolus insulin reduction initiated by the user (e.g. 25–33% reduction) prior to activity, then glucose will likely rise and result in automated insulin delivery by the system, thereby increasing hypoglycaemia risk during PA. The gene discussed is INS; the disease is Hypoglycemia.